Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer

Cisplatin is a promising therapeutic for the treatment of non-small cell lung cancer (NSCLC). Unfortunately, a significant portion of NSCLC patients relapse due to cisplatin chemoresistance. This chemoresistance is thought to be primarily associated with hypoxia in the tumor microenvironment. Admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucas, Alfredo, Belcher, Donald A., Munoz, Carlos, Williams, Alexander T., Palmer, Andre F., Cabrales, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584239/
https://www.ncbi.nlm.nih.gov/pubmed/33144918
http://dx.doi.org/10.18632/oncotarget.27776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584239/
https://www.ncbi.nlm.nih.gov/pubmed/33144918
http://dx.doi.org/10.18632/oncotarget.27776

Ejemplares similares